Innoviva (INVA) Enterprise Value Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -89.00% |
| Dec 31, 2025 | -80.66% |
| Sep 30, 2025 | -82.83% |
| Jun 30, 2025 | -83.19% |
| Mar 31, 2025 | -78.91% |
| Dec 31, 2024 | -57.59% |
| Sep 30, 2024 | -44.80% |
| Jun 30, 2024 | -25.42% |
| Mar 31, 2024 | -23.82% |
| Dec 31, 2023 | 33.51% |
| Sep 30, 2023 | 40.21% |
| Jun 30, 2023 | 38.99% |
| Mar 31, 2023 | 33.56% |
| Dec 31, 2022 | -222.20% |
| Sep 30, 2022 | -552.79% |
| Jun 30, 2022 | -1,469.95% |
| Mar 31, 2022 | 1.75% |
| Dec 31, 2021 | 49.41% |
| Sep 30, 2021 | 89.27% |
| Jun 30, 2021 | 105.43% |
| Mar 31, 2021 | 38.30% |
| Dec 31, 2020 | 44.58% |
| Sep 30, 2020 | -53.26% |
| Jun 30, 2020 | -66.01% |
| Mar 31, 2020 | -98.15% |
| Dec 31, 2019 | -194.43% |
| Sep 30, 2019 | -435.30% |
| Jun 30, 2019 | -117.57% |
| Mar 31, 2019 | -224.32% |
| Dec 31, 2018 | 15.11% |
| Sep 30, 2018 | 68.85% |
| Jun 30, 2018 | 22.18% |
| Mar 31, 2018 | 67.23% |
| Dec 31, 2017 | 14.30% |
| Sep 30, 2017 | -12.91% |
| Jun 30, 2017 | 11.85% |
| Mar 31, 2017 | -0.96% |
| Dec 31, 2016 | 19.68% |
| Sep 30, 2016 | 27.75% |
| Jun 30, 2016 | 32.89% |
| Mar 31, 2016 | 33.03% |
| Dec 31, 2015 | 22.13% |
| Sep 30, 2015 | 21.63% |
| Jun 30, 2015 | 31.46% |
| Mar 31, 2015 | 32.29% |
| Dec 31, 2014 | 48.29% |
| Sep 30, 2014 | 48.02% |
| Jun 30, 2014 | 24.50% |
| Mar 31, 2014 | 19.20% |
| Dec 31, 2013 | -87.18% |
| Sep 30, 2013 | -85.10% |
| Jun 30, 2013 | -49.92% |
| Mar 31, 2013 | -129.34% |
| Dec 31, 2012 | -3.14% |
| Sep 30, 2012 | -3.12% |
| Jun 30, 2012 | -4.09% |
| Mar 31, 2012 | -35.36% |
| Dec 31, 2011 | 22.19% |
| Sep 30, 2011 | -320.23% |
| Jun 30, 2011 | -307.18% |
| Dec 31, 2010 | -551.19% |